I am glad that the ~ first issue of the Journal of Geriatric Psychiatry and Neurology is now off and running. We have had a good response to our initial call for papers and the articles within are scientific, educational, and practical. I thank those of you who have written in support of the journal and also those who think such a journal is a terrible idea. It is my hope that this journal will indeed provide a forum for researchers and clinicians to present their work and ideas on topics that have to do with geriatric psychiatry and neurology. I The preliminary work on this journal has not been without conflict, as some feel that psychiatry and neurology should remain separate and that the journal should just focus on psychiatric aspects of the care of the elderly. Others feel strongly that psychiatry and neurology are inseparable if one is to adequately assess and treat illness in the elderly. Whether or not the two disciplines should remain separate is beyond the scope of the journal (although discussions about this topic would be welcome in the Letters to the Editor section), but it is my goal to make this journal relevant to both disciplines and to be of interest to all physicians who care for the elderly.
Many of the articles in this first issue pertain to elderly patients with some form of brain damage or dementia. Dr Francene Benes and colleagues of McLean Hospital and Massachusetts General Hospital report on a previously unknown aspect of brain cytoarchitecture in patients with normal aging and in those with Alzheimer's disease. Using sophisticated immunolocalization procedures they showed that certain brain areas retain intact cytoarchitecture through the ninth decade, while in other areas there is disruption after the fifth decade. Patients with Alzheimer's disease showed a marked disruption of the modular arrangement of fibers in some areas but not in others.
They plan to continue similar work in patients with
Parkinson's disease and multi-infarct dementia to determine whether these findings are specific to patients with Alzheimer's disease.
Dr Eugene Rubin and associates from Washington University School of Medicine in St Louis have evaluated and characterized the nature of psychotic symptoms in patients with Alzheimer's disease and found three main groups to be most common: paranoid delusions, misidentification syndromes, and hallucinations.
Dr John Patterson of the University of Missouri focuses on a possible treatment for assaultive or aggressive dementing patients. From his report, it appears that carbamazepine (Tegretol) may well be worth a try in these patients.
Dr Jeffrey Cummings of the UCLA School of Medicine has done a thorough job of reviewing intellectual impairment in patients with Parkinson's disease and reports the remarkable figure that almost 40% of these patients have evidence of overt dementia. This figure was derived from his review of 27 studies involving 4,336 patients. He discusses implications of this finding. Dr Philip Smeraski of East Carolina University School of Medicine reports on one patient with multiinfarct dementia whose agitation, hyperactivity, and impulsive violence were well controlled with the benzodiazepine clonazepam.
Drs Alastair Flint and Robin Eastwood have evaluated the relationship of frontal lobe syndrome to depression, an area which is often clinically confusing. They note that frontal lobe disorders may Continued on page 59
